Mustang Bio Inc. (NASDAQ:MBIO) went up by 5.53% from its latest closing price compared to the recent 1-year high of $4.85. The company’s stock price has collected 11.14% of gains in the last five trading sessions. Press Release reported on 01/05/21 that Mustang Bio to Participate in Three January 2021 Virtual Investor Conferences
Is It Worth Investing in Mustang Bio Inc. (NASDAQ :MBIO) Right Now?
Plus, the 36-month beta value for MBIO is at 1.84. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Mustang Bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $10.75. MBIO currently public float of 50.58M and currently shorts hold a 10.25% ratio of that float. Today, the average trading volume of MBIO was 2.93M shares.
MBIO’s Market Performance
MBIO stocks went up by 11.14% for the week, with a monthly jump of 52.43% and a quarterly performance of 30.27%, while its annual performance rate touched 5.78%. The volatility ratio for the week stands at 10.01% while the volatility levels for the past 30 days are set at 9.84% for Mustang Bio Inc.. The simple moving average for the period of the last 20 days is 23.38% for MBIO stocks with a simple moving average of 36.81% for the last 200 days.
Analysts’ Opinion of MBIO
Many brokerage firms have already submitted their reports for MBIO stocks, with B. Riley FBR repeating the rating for MBIO by listing it as a “Buy.” The predicted price for MBIO in the upcoming period, according to B. Riley FBR is $9 based on the research report published on October 02nd of the previous year 2020.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see MBIO reach a price target of $7. The rating they have provided for MBIO stocks is “Overweight” according to the report published on November 20th, 2019.
H.C. Wainwright gave a rating of “Buy” to MBIO, setting the target price at $7 in the report published on August 13th of the previous year.
MBIO Trading at 32.98% from the 50-Day Moving Average
After a stumble in the market that brought MBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.48% of loss for the given period.
Volatility was left at 9.84%, however, over the last 30 days, the volatility rate increased by 10.01%, as shares surge +52.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +59.06% upper at present.
During the last 5 trading sessions, MBIO rose by +11.14%, which changed the moving average for the period of 200-days by +62.59% in comparison to the 20-day moving average, which settled at $3.63. In addition, Mustang Bio Inc. saw 15.98% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at MBIO starting from Litchman Manuel MD, who purchase 100,000 shares at the price of $2.91 back on Dec 15. After this action, Litchman Manuel MD now owns 654,846 shares of Mustang Bio Inc., valued at $291,000 using the latest closing price.
ROSENWALD LINDSAY A MD, the Director of Mustang Bio Inc., purchase 100,000 shares at $2.66 during a trade that took place back on Dec 14, which means that ROSENWALD LINDSAY A MD is holding 200,423 shares at $266,000 based on the most recent closing price.
Stock Fundamentals for MBIO
The total capital return value is set at -88.60, while invested capital returns managed to touch -90.90. Equity return is now at value -90.80, with -68.50 for asset returns.
Based on Mustang Bio Inc. (MBIO), the company’s capital structure generated 30.06 points at debt to equity in total, while total debt to capital is 23.12. Total debt to assets is 21.14, with long-term debt to equity ratio resting at 27.15. Finally, the long-term debt to capital ratio is 20.87.
The liquidity ratio also appears to be rather interesting for investors as it stands at 8.12.